Health Care & Life Sciences » Pharmaceuticals | Kainos Laboratories Inc.

Kainos Laboratories Inc. | Cash Flow

Fiscal year is April-March. All values JPY Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
313,183.00
378,082.00
437,010.00
457,997.00
379,233.00
Depreciation, Depletion & Amortization
133,990.00
136,238.00
143,156.00
132,605.00
110,219.00
Other Funds
70,734.00
46,532.00
167,557.00
109,365.00
53,065.00
Funds from Operations
376,439.00
467,788.00
412,609.00
481,238.00
436,388.00
Changes in Working Capital
13,248.00
74,324.00
111,748.00
107,897.00
98,504.00
Net Operating Cash Flow
389,687.00
393,464.00
300,861.00
373,341.00
337,884.00
Capital Expenditures
45,719.00
40,806.00
162,099.00
70,112.00
171,252.00
Purchase/Sale of Investments
-
-
-
-
99,998.00
Net Investing Cash Flow
46,626.00
41,437.00
160,885.00
70,218.00
265,926.00
Cash Dividends Paid - Total
33,562.00
33,559.00
55,751.00
54,716.00
56,115.00
Issuance/Reduction of Debt, Net
141,751.00
134,676.00
127,764.00
185,896.00
21,207.00
Net Financing Cash Flow
175,521.00
168,432.00
344,537.00
240,772.00
77,322.00
Net Change in Cash
167,549.00
183,607.00
205,863.00
61,015.00
5,370.00
Free Cash Flow
344,868.00
357,821.00
141,570.00
303,769.00
281,333.00
Other Sources
593.00
1,305.00
1,214.00
1,088.00
5,324.00
Change in Capital Stock
208.00
197.00
161,022.00
160.00
-
Exchange Rate Effect
9.00
12.00
1,302.00
1,336.00
6.00
Other Uses
1,500.00
1,936.00
-
1,193.00
-

About Kainos Laboratories

View Profile
Address
2-38-18 Hongo
Tokyo Tokyo 113
Japan
Employees -
Website http://www.kainos.co.jp
Updated 09/14/2018
Kainos Laboratories, Inc. engages in the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products. It is also involved in the development, manufacture, marketing, distribution, import and export of physical and chemical measurement instruments, medical supplies, nutrition supplements, foodstuff, animal feed and related products. The company was founded on May 1, 1975 and is headquartered in Tokyo, Japan.